glp 1 medication shortage GLP-1s Going Direct, How Novo and Lilly's DTC Strategy is Changing the Game for Patients and Plan Sponsors Shortages improve for Lilly's GLP-1
Description
Instead of pills or painful injections, these transdermal patches deliver active ingredients directly through the skin offering a gentle, convenient, and effective solution

These actions have been clinically exploited by the development of amylin and GLP-1 hormone analogs now used for treatment of diabetes and obesity

A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 medications semaglutide or liraglutide were less likely to have suicidal thoughts or attempts than those treated with behavioral interventions.
Read more: bit.ly/46uQ5dg #GLP1 #FDAgreenlist #healthcare
(2025) explores current evidence, challenges, and future perspectives in managing surgical patients on GLP-1R agonists
